Daiwa Securities Group Inc. - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 151 filers reported holding TRANSLATE BIO INC in Q4 2020. The put-call ratio across all filers is 7.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$4,000
+100.0%
1400.0%0.00%
Q1 2021$2,000
-33.3%
1400.0%0.00%
Q4 2020$3,000
-40.0%
140
-59.2%
0.00%
Q3 2020$5,000
+66.7%
343
+19.5%
0.00%
Q2 2020$3,0000.0%2870.0%0.00%
Q1 2020$3,000
+50.0%
2870.0%0.00%
Q4 2019$2,000
-33.3%
2870.0%0.00%
Q3 2019$3,000
-25.0%
2870.0%0.00%
Q2 2019$4,000
+33.3%
2870.0%0.00%
Q1 2019$3,000
-40.0%
287
-55.8%
0.00%
Q4 2018$5,0006500.00%
Other shareholders
TRANSLATE BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 2,656,517$48,960,00010.98%
Copernicus Capital Management, LLC 12,091$223,0003.48%
FRAZIER MANAGEMENT LLC 2,182,789$40,229,0003.10%
Baupost Group 18,044,239$326,236,0003.01%
DAFNA Capital Management LLC 225,393$4,154,0001.24%
RTW INVESTMENTS, LP 2,978,427$54,892,0000.92%
MARATHON CAPITAL MANAGEMENT 143,275$2,640,0000.78%
Bain Capital Public Equity Management II, LLC 627,387$11,563,0000.59%
Artal Group S.A. 1,200,000$22,116,0000.48%
Birchview Capital, LP 30,000$553,0000.32%
View complete list of TRANSLATE BIO INC shareholders